EUVIMEDEUVIMED entdecken
Open Access

Cell surface engineering with a pseudofibrotic ECM reprograms the antifibrotic activity of mesenchymal stromal cells

Xianghua Zhong iD, Xinchao Liu iD, Jiajia Luo iD, Xinyang Liu iD, Xueting Wei iD, Xi Peng iD, Lu Wang iD, Huaimin Wang iD, Kunyu Zhang iD, Liming Bian iD, Peng Shi iD

Science Advances · 2026

DOI: 10.1126/sciadv.aea0998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Xianghua Zhong und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, P. R. China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Extracellular Matrix, Cell Engineering. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Guandong Natural Science Foundation, Fundamental Research Funds for the Central Universities, National key R&D program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrotic diseases, which impair tissue function and contribute to organ failure, remain a major clinical challenge with limited treatment options. Mesenchymal stromal cells (MSCs) offer promise for antifibrotic therapy via paracrine signaling, but their clinical efficacy is hindered by poor survival and limited functional activity after transplantation. Here, we present a cell surface engineering strategy that reprograms the antifibrotic function of MSCs by constructing a pseudofibrotic extracellular matrix (ECM) on their surface. Through in situ self-assembly of peptide-modified hyaluronic acid, we generate a nanofiber-based matrix that mimics the dense, disordered architecture of fibrotic ECM. This matrix activates the Piezo1/PI3K-Akt signaling pathway, inducing up-regulation of Mmp13—a key collagen-degrading matrix metalloproteinase—in engineered MSCs. In a rat model of myocardial infarction–associated fibrosis, engineered MSCs exhibit robust antifibrotic activity compared to unmodified MSCs. These findings establish a bioinspired strategy for MSC reprogramming and offer a path toward more effective cell-based therapies for fibrotic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsExtracellular MatrixCell EngineeringAnimalsRatsFibrosisHumansSignal TransductionHyaluronic AcidMyocardial Infarction

Substanzen

Hyaluronic Acid

Autor:innen und Institutionen

  • School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, P. R. China.
  • Center of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine and PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, Guangzhou 510630, P. R. China.
  • Department of Chemistry, School of Science, Westlake University, Hangzhou 310024, P. R. China.
  • National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou 510006, P. R. China.
  • Guangdong Provincial Key Laboratory of Biomedical Engineering, South China University of Technology, Guangzhou 510006, P. R. China.

ORCID-Profile: Xianghua Zhong, Xinchao Liu, Jiajia Luo, Xinyang Liu, Xueting Wei, Xi Peng, Lu Wang, Huaimin Wang, Kunyu Zhang, Liming Bian, Peng Shi

Förderung

  • Guandong Natural Science Foundation
  • Fundamental Research Funds for the Central Universities
  • National key R&D program of China
  • Guangzhou Basic and Applied Basic Research Foundation
  • GJYC program of Guangzhou

Zitieren

APA

Zhong, X., Liu, X., Luo, J., Liu, X., Wei, X., Peng, X., Wang, L., Wang, H., Zhang, K., Bian, L., & Shi, P. (2026). Cell surface engineering with a pseudofibrotic ECM reprograms the antifibrotic activity of mesenchymal stromal cells. Science Advances. https://doi.org/10.1126/sciadv.aea0998

Vancouver

Zhong X, Liu X, Luo J, Liu X, Wei X, Peng X, et al. Cell surface engineering with a pseudofibrotic ECM reprograms the antifibrotic activity of mesenchymal stromal cells. Science Advances. 2026. doi:10.1126/sciadv.aea0998

BibTeX
@article{Zhong2026,
  author = {Zhong, Xianghua and Liu, Xinchao and Luo, Jiajia and Liu, Xinyang and Wei, Xueting and Peng, Xi and Wang, Lu and Wang, Huaimin and Zhang, Kunyu and Bian, Liming and Shi, Peng},
  title = {Cell surface engineering with a pseudofibrotic ECM reprograms the antifibrotic activity of mesenchymal stromal cells},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aea0998}
}
Kostenlos starten →